Freeline to present at the 3rd Annual Evercore ISI Health CONx Conference
LONDON, Nov. 19, 2020 (GLOBE NEWSWIRE) -- Freeline Therapeutics Holdings plc (Nasdaq: FRLN) (the “Company” or “Freeline”), a clinical-stage, fully integrated, next generation, systemic AAV-based gene therapy company with the ambition of transforming the lives of patients suffering from inherited systemic debilitating diseases, today announced that management will participate in a fireside chat at the 3rd Annual Evercore ISI Health CONx Conference on 3 December, 2020 from 08.00 – 8.20 am ET.
A live audio webcast of the fireside chat will be available on the events section of Freeline’s website. An archived replay will be available on the Company’s website for a period of 90 days after the conference.
For further information, please reference the Company’s reports and documents filed with the U.S. Securities and Exchange Commission. You may get these documents by visiting EDGAR on the SEC website at www.sec.gov.
Exhibit Hall Open - Hall D
Time: 11:00am 4:00pm
Utilizing Machine Learning to Predict Public Transportation Times
All Conference Party